DOI: 10.1055/s-00033101

Neurology International Open

Referenz

Howard JF, Barohn RJ, Cutter GR. et al.
A randomized, double-blind, placebo-controled phase II study of eculizumab in patients with refractory generalized myasthenia gravis.

Muscle Nerve 2013;
48: 76-84

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: